Jennifer Frederick didn't understand why she had a growing lump under her skin. A doctor returned a devastating diagnosis.

The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL ...

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

The NBA may finally be one step closer on the long road to expansion. Saying owners have a “curiosity” about the notion, ...

Felipe Escobedo from Georgia said he was documenting a social media trend when he spotted a painless lump in his neck.

Tiny, newly formed tumors shed small fragments of DNA that are swept into the bloodstream. Future cancer screening tests could detect them early.

Healthy organs in the body are spared, on the other hand. In almost a third of all lymphoma patients, the tumor cells produce the CD30 receptor—in these patients the new treatment could be applied.

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years.

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy advances that offer more approaches.